https://endpoints.news/novartis-to-buy-rna-drugmaker-avidity-biosciences-for-12b/
Novartis to buy RNA drugmaker Avidity Biosciences for $12B
Oct 27, 2025 - Novartis to acquire Avidity Biosciences for $12B, gaining access to three neuromuscular drug candidates nearing FDA submission. Deal includes spinout of cardio...
avidity biosciencesnovartis
https://www.propublica.org/article/fda-inspections-sun-pharma-drug-exemptions
Indian Drugmaker Sun Pharma Made Promises to the FDA that It Didn’t Keep — ProPublica
Aug 12, 2025 - Documents obtained by ProPublica offer a rare glimpse into discussions between the global drugmaker Sun Pharma and the FDA, exposing how the agency tolerated...
sun pharmaindiandrugmakermade
https://www.investopedia.com/this-drugmaker-stock-is-soaring-over-40-percent-monday-kymr-11864063
This Drugmaker's Stock Is Soaring Over 40% Monday
Kymera Therapeutics shares jumped to a record high Monday after the drugmaker reported positive results from a trial of its experimental anti-inflammatory drug.
drugmakerstocksoaringmonday
https://www.ibtimes.co.uk/nhs-refuses-fund-life-saving-motor-neurone-disease-medication-despite-free-supply-drugmaker-1766381
NHS Refuses to Fund Life-Saving Motor Neurone Disease Medication Despite Free Supply From Drugmaker...
Dec 28, 2025 - MND patients in the UK denied access to lifesaving drug tofersen, despite Biogen supplying it free, due to NHS covering administration costs.
motor neurone diseasenhsfund